|
1
|
Thapar A and Cooper M: Attention deficit
hyperactivity disorder. Lancet. 387:1240–1250. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dalsgaard S, Ostergaard SD, Leckman JF,
Mortensen PB and Pedersen MG: Mortality in children, adolescents,
and adults with attention deficit hyperactivity disorder: A
nationwide cohort study. Lancet. 385:2190–2196. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Howlett JR, Campbell-Sills L, Jain S,
Heeringa SG, Nock MK, Sun X, Ursano RJ and Stein MB: Attention
deficit hyperactivity disorder and risk of posttraumatic stress and
related disorders: A prospective longitudinal evaluation in U.S.
army soldiers. J Trauma Stress. 31:909–918. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ahmed R, Borst JM, Yong CW and Aslani P:
Do parents of children with attention-deficit/hyperactivity
disorder (ADHD) receive adequate information about the disorder and
its treatments? A qualitative investigation. Patient Prefer
Adherence. 8:661–670. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hawi Z, Cummins TD, Tong J, Johnson B, Lau
R, Samarrai W and Bellgrove MA: The molecular genetic architecture
of attention deficit hyperactivity disorder. Mol Psychiatry.
20:289–297. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Posner J, Polanczyk GV and Sonuga-Barke E:
Attention-deficit hyperactivity disorder. Lancet. 395:450–462.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Williams NM, Zaharieva I, Martin A,
Langley K, Mantripragada K, Fossdal R, Stefansson H, Stefansson K,
Magnusson P, Gudmundsson OO, et al: Rare chromosomal deletions and
duplications in attention-deficit hyperactivity disorder: A
genome-wide analysis. Lancet. 376:1401–1408. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Thapar A, Cooper M, Eyre O and Langley K:
What have we learnt about the causes of ADHD? J Child Psychol
Psychiatry. 54:3–16. 2013.
|
|
9
|
Thompson JM, Waldie KE, Wall CR, Murphy R
and Mitchell EA: ABC study group: Associations between
acetaminophen use during pregnancy and ADHD symptoms measured at
ages 7 and 11 years. PLoS One. 9(e108210)2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Harold GT, Leve LD, Barrett D, Elam K,
Neiderhiser JM, Natsuaki MN, Shaw DS, Reiss D and Thapar A:
Biological and rearing mother influences on child ADHD symptoms:
Revisiting the developmental interface between nature and nurture.
J Child Psychol Psychiatry. 54:1038–1046. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Waltes R, Freitag CM, Herlt T, Lempp T,
Seitz C, Palmason H, Meyer J and Chiocchetti AG: Impact of
autism-associated genetic variants in interaction with
environmental factors on ADHD comorbidities: An exploratory pilot
study. J Neural Transm (Vienna). 126:1679–1693. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Grisham JR, Fullana MA, Mataix-Cols D,
Moffitt TE, Caspi A and Poulton R: Risk factors prospectively
associated with adult obsessive-compulsive symptom dimensions and
obsessive-compulsive disorder. Psychol Med. 41:2495–2506.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Russell VA: Overview of animal models of
attention deficit hyperactivity disorder (ADHD). Curr Protoc
Neurosci. 9:9–35. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hoogman M, Bralten J, Hibar DP, Mennes M,
Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E,
Jahanshad N, et al: Subcortical brain volume differences in
participants with attention deficit hyperactivity disorder in
children and adults: A cross-sectional mega-analysis. Lancet
Psychiatry. 4:310–319. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gurkan K, Bilgic A, Turkoglu S, Kilic BG,
Aysev A and Uslu R: Depression, anxiety and obsessive-compulsive
symptoms and quality of life in children with attention-deficit
hyperactivity disorder (ADHD) during three-month methylphenidate
treatment. J Psychopharmacol. 24:1810–1818. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wilens TE: Effects of methylphenidate on
the catecholaminergic system in attention-deficit/hyperactivity
disorder. J Clin Psychopharmacol. 28 (3 Suppl 2):S46–S53.
2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lyman M, Lloyd DG, Ji X, Vizcaychipi MP
and Ma D: Neuroinflammation: The role and consequences. Neurosci
Res. 79:1–12. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Milo R, Korczyn AD, Manouchehri N and
Stüve O: The temporal and causal relationship between inflammation
and neurodegeneration in multiple sclerosis. Mult Scler.
4(1352458519886943)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Varley J, Brooks DJ and Edison P: Imaging
neuroinflammation in Alzheimer's disease and other dementias:
Recent advances and future directions. Alzheimers Dement.
11:1110–1120. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bradburn S, Murgatroyd C and Ray N:
Neuroinflammation in mild cognitive impairment and Alzheimer's
disease: A meta-analysis. Ageing Res Rev. 50:1–8. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jayaraj RL, Azimullah S, Beiram R, Jalal
FY and Rosenberg GA: Neuroinflammation: Friend and foe for ischemic
stroke. J Neuroinflammation. 16(142)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Woelfer M, Kasties V, Kahlfuss S and
Walter M: The role of depressive subtypes within the
neuroinflammation hypothesis of major depressive disorder.
Neuroscience. 403:93–110. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matta SM, Hill-Yardin EL and Crack PJ: The
influence of neuroinflammation in autism spectrum disorder. Brain
Behav Immun. 79:75–90. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Calabrese V, Giordano J, Crupi R, Di Paola
R, Ruggieri M, Bianchini R, Ontario ML, Cuzzocrea S and Calabrese
EJ: Hormesis, cellular stress response and neuroinflammation in
schizophrenia: Early onset versus late onset state. J Neurosci Res.
95:1182–1193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Huh Y, Ji RR and Chen G:
Neuroinflammation, bone marrow stem cells, and chronic pain. Front
Immunol. 8(1014)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lucas SM, Rothwell NJ and Gibson RM: The
role of inflammation in CNS injury and disease. Br J Pharmacol. 147
(Suppl 1):S232–S240. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Skaper SD, Facci L, Zusso M and Giusti P:
An inflammation-centric view of neurological disease: Beyond the
neuron. Front Cell Neurosci. 12(72)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Colonna M and Butovsky O: Microglia
function in the central nervous system during health and
neurodegeneration. Annu Rev Immunol. 35:441–468. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Skaper SD, Giusti P and Facci L: Microglia
and mast cells: Two tracks on the road to neuroinflammation. FASEB
J. 26:3103–3117. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang CJ, Jiang M, Zhou H, Liu W, Wang C,
Kang Z, Han B, Zhang Q, Chen X, Xiao J, et al: TLR-stimulated IRAKM
activates caspase-8 inflammasome in microglia and promotes
neuroinflammation. J Clin Invest. 128:5399–5412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xiong XY, Liu L and Yang QW: Functions and
mechanisms of microglia/macrophages in neuroinflammation and
neurogenesis after stroke. Prog Neurobiol. 142:23–44.
2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Colombo E and Farina C: Astrocytes: Key
regulators of neuroinflammation. Trends Immunol. 37:608–620.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Montoya A, Elgueta D, Campos J, Chovar O,
Falcón P, Matus S, Alfaro I, Bono MR and Pacheco R: Dopamine
receptor D3 signalling in astrocytes promotes neuroinflammation. J
Neuroinflammation. 16(258)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kempuraj D, Selvakumar GP, Thangavel R,
Ahmed ME, Zaheer S, Raikwar SP, Iyer SS, Bhagavan SM,
Beladakere-Ramaswamy S and Zaheer A: Mast cell activation in brain
injury, stress, and post-traumatic stress disorder and Alzheimer's
disease pathogenesis. Front Neurosci. 11(703)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Krystel-Whittemore M, Dileepan KN and Wood
JG: Mast cell: A multi-functional master cell. Front Immunol.
6(620)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gilfillan AM, Austin SJ and Metcalfe DD:
Mast cell biology: Introduction and overview. Adv Exp Med Biol.
716:2–12. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Prussin C and Metcalfe DD: 4. IgE, mast
cells, basophils, and eosinophils. J Allergy Clin Immunol. 111
(Suppl 2):S486–S494. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Vyas H and Krishnaswamy G: Paul Ehrlich's
‘Mastzellen’-from aniline dyes to DNA chip arrays: A historical
review of developments in mast cell research. Methods Mol Biol.
315:3–11. 2006.PubMed/NCBI
|
|
39
|
Irani AM and Schwartz LB: Human mast cell
heterogeneity. Allergy Proc. 15:303–308. 1994.PubMed/NCBI View Article : Google Scholar
|
|
40
|
da Silva EZ, Jamur MC and Oliver C: Mast
cell function: A new vision of an old cell. J Histochem Cytochem.
62:698–738. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Polyzoidis S, Koletsa T, Panagiotidou S,
Ashkan K and Theoharides TC: Mast cells in meningiomas and brain
inflammation. J Neuroinflammation. 12(170)2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Galli SJ and Tsai M: IgE and mast cells in
allergic disease. Nat Med. 18:693–704. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Kritikou E, Kuiper J, Kovanen PT and Bot
I: The impact of mast cells on cardiovascular diseases. Eur J
Pharmacol. 778:103–115. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sant GR, Kempuraj D, Marchand JE and
Theoharides TC: The mast cell in interstitial cystitis: Role in
pathophysiology and pathogenesis. Urology. 69 (Suppl 4):S34–S40.
2007.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Suurmond J, van der Velden D, Kuiper J,
Bot I and Toes RE: Mast cells in rheumatic disease. Eur J
Pharmacol. 778:116–124. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Theoharides TC, Donelan J,
Kandere-Grzybowska K and Konstantinidou A: The role of mast cells
in migraine pathophysiology. Brain Res Brain Res Rev. 49:65–76.
2005.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Theoharides TC, Angelidou A, Alysandratos
KD, Zhang B, Asadi S, Francis K, Toniato E and Kalogeromitros D:
Mast cell activation and autism. Biochim Biophys Acta. 1822:34–41.
2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Boyce JA: Mast cells and eicosanoid
mediators: A system of reciprocal paracrine and autocrine
regulation. Immunol Rev. 217:168–185. 2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Dong H, Wang Y, Zhang X, Zhang X, Qian Y,
Ding H and Zhang S: Stabilization of brain mast cells alleviates
LPS-induced neuroinflammation by inhibiting microglia activation.
Front Cell Neurosci. 13(191)2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Forsythe P: Mast cells in neuroimmune
interactions. Trends Neurosci. 42:43–55. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Theoharides TC, Kempuraj D, Tagen M, Conti
P and Kalogeromitros D: Differential release of mast cell mediators
and the pathogenesis of inflammation. Immunol Rev. 217:65–78.
2007.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Theoharides TC and Cochrane DE: Critical
role of mast cells in inflammatory diseases and the effect of acute
stress. J Neuroimmunol. 146:1–12. 2004.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Theoharides TC, Sieghart W, Greengard P
and Douglas WW: Antiallergic drug cromolyn may inhibit histamine
secretion by regulating phosphorylation of a mast cell protein.
Science. 207:80–82. 1980.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Dvorak AM: Basophils and mast cells:
Piecemeal degranulation in situ and ex vivo: A possible mechanism
for cytokine-induced function in disease. Immunol Ser. 57:169–271.
1992.PubMed/NCBI
|
|
55
|
Pang X, Letourneau R, Rozniecki JJ, Wang L
and Theoharides TC: Definitive characterization of rat hypothalamic
mast cells. Neuroscience. 73:889–902. 1996.PubMed/NCBI View Article : Google Scholar
|
|
56
|
van Haaster CM, Engels W, Lemmens PJ,
Hornstra G, van der Vusse GJ and Heemskerk JW: Differential release
of histamine and prostaglandin D2 in rat peritoneal mast cells:
Roles of cytosolic calcium and protein tyrosine kinases. Biochim
Biophys Acta. 1265:79–88. 1995.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lee CC, Avalos AM and Ploegh HL: Accessory
molecules for Toll-like receptors and their function. Nat Rev
Immunol. 12:168–179. 2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
McCurdy JD, Olynych TJ, Maher LH and
Marshall JS: Cutting edge: Distinct Toll-like receptor 2 activators
selectively induce different classes of mediator production from
human mast cells. J Immunol. 170:1625–1629. 2003.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Sismanopoulos N, Delivanis DA,
Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D and
Theoharides TC: Mast cells in allergic and inflammatory diseases.
Curr Pharm Des. 18:2261–2277. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Cao J, Cetrulo CL and Theoharides TC:
Corticotropin-releasing hormone induces vascular endothelial growth
factor release from human mast cells via the cAMP/protein kinase
A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol.
69:998–1006. 2006.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Alysandratos KD, Asadi S, Angelidou A,
Zhang B, Sismanopoulos N, Yang H, Critchfield A and Theoharides TC:
Neurotensin and CRH interactions augment human mast cell
activation. PLoS One. 7(e48934)2012.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kandere-Grzybowska K, Letourneau R,
Kempuraj D, Donelan J, Poplawski S, Boucher W, Athanassiou A and
Theoharides TC: IL-1 induces vesicular secretion of IL-6 without
degranulation from human mast cells. J Immunol. 171:4830–4836.
2003.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Bawazeer MA and Theoharides TC: IL-33
stimulates human mast cell release of CCL5 and CCL2 via MAPK and
NF-kB, inhibited by methoxyluteolin. Eur J Pharmacol.
865(172760)2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Theoharides TC and Leeman SE: Effect of
IL-33 on de novo synthesized mediators from human mast cells. J
Allergy Clin Immunol. 143(451)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Taracanova A, Tsilioni I, Conti P, Norwitz
ER, Leeman SE and Theoharides TC: Substance P and IL-33
administered together stimulate a marked secretion of IL-1β from
human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci
USA. 115:E9381–E9390. 2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Drube S, Kraft F, Dudeck J, Muller AL,
Weber F, Gopfert C, Meininger I, Beyer M, Irmler I, Hafner N, et
al: MK2/3 are pivotal for IL-33-induced and mast cell-dependent
leukocyte recruitment and the resulting skin inflammation. J
Immunol. 197:3662–3668. 2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Gasque P, Singhrao SK, Neal JW, Gotze O
and Morgan BP: Expression of the receptor for complement C5a (CD88)
is up-regulated on reactive astrocytes, microglia, and endothelial
cells in the inflamed human central nervous system. Am J Pathol.
150:31–41. 1997.PubMed/NCBI
|
|
68
|
Pundir P, MacDonald CA and Kulka M: The
novel receptor C5aR2 is required for C5a-mediated human mast cell
adhesion, migration, and proinflammatory mediator production. J
Immunol. 195:2774–2787. 2015.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Yuan B, Fu F, Huang S, Lin C, Yang G, Ma
K, Shi H and Yang Z: C5a/C5aR pathway plays a vital role in brain
inflammatory injury via initiating fgl-2 in intracerebral
hemorrhage. Mol Neurobiol. 54:6187–6197. 2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Perkins DJ and Vogel SN: Inflammation:
Species-specific TLR signalling-insight into human disease. Nat Rev
Rheumatol. 12:198–200. 2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Skaper SD: Impact of Inflammation on the
blood-neural barrier and blood-nerve interface: From review to
therapeutic preview. Int Rev Neurobiol. 137:29–45. 2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Yasuoka S, Kawanokuchi J, Parajuli B, Jin
S, Doi Y, Noda M, Sonobe Y, Takeuchi H, Mizuno T and Suzumura A:
Production and functions of IL-33 in the central nervous system.
Brain Res. 1385:8–17. 2011.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Burnstock G, Krugel U, Abbracchio MP and
Illes P: Purinergic signalling: From normal behaviour to
pathological brain function. Prog Neurobiol. 95:229–274.
2011.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Chakraborty S, Kaushik DK, Gupta M and
Basu A: Inflammasome signaling at the heart of central nervous
system pathology. J Neurosci Res. 88:1615–1631. 2010.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Kempuraj D, Thangavel R, Selvakumar GP,
Ahmed ME, Zaheer S, Raikwar SP, Zahoor H, Saeed D, Dubova I, Giler
G, et al: Mast cell proteases activate astrocytes and glia-neurons
and release interleukin-33 by activating p38 and ERK1/2 MAPKs and
NF-κB. Mol Neurobiol. 56:1681–1693. 2019.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Zhang S, Zeng X, Yang H, Hu G and He S:
Mast cell tryptase induces microglia activation via
protease-activated receptor 2 signaling. Cell Physiol Biochem.
29:931–940. 2012.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Pietrzak A, Wierzbicki M, Wiktorska M and
Brzezinska-Blaszczyk E: Surface TLR2 and TLR4 expression on mature
rat mast cells can be affected by some bacterial components and
proinflammatory cytokines. Mediators Inflamm.
2011(427473)2011.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zhang H, Lin L, Yang H, Zhang Z, Yang X,
Zhang L and He S: Induction of IL-13 production and upregulation of
gene expression of protease activated receptors in P815 cells by
IL-6. Cytokine. 50:138–145. 2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Zhang H, Yang H and He S: TNF increases
expression of IL-4 and PARs in mast cells. Cell Physiol Biochem.
26:327–336. 2010.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Wang X, Li C, Chen Y, Hao Y, Zhou W, Chen
C and Yu Z: Hypoxia enhances CXCR4 expression favoring microglia
migration via HIF-1alpha activation. Biochem Biophys Res Commun.
371:283–288. 2008.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Wang Y, Huang J, Li Y and Yang GY: Roles
of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug
Targets. 13:166–172. 2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Dong Y and Benveniste EN: Immune function
of astrocytes. Glia. 36:180–190. 2001.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Kim DY, Hong GU and Ro JY: Signal pathways
in astrocytes activated by cross-talk between of astrocytes and
mast cells through CD40-CD40L. J Neuroinflammation.
8(25)2011.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Seeldrayers PA, Levin LA and Johnson D:
Astrocytes support mast cell viability in vitro. J Neuroimmunol.
36:239–243. 1992.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Dong H, Zhang W, Zeng X, Hu G, Zhang H, He
S and Zhang S: Histamine induces upregulated expression of
histamine receptors and increases release of inflammatory mediators
from microglia. Mol Neurobiol. 49:1487–1500. 2014.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Mele T and Juric DM: Identification and
pharmacological characterization of the histamine H3 receptor in
cultured rat astrocytes. Eur J Pharmacol. 720:198–204.
2013.PubMed/NCBI
|
|
87
|
Medic N, Vita F, Abbate R, Soranzo MR,
Pacor S, Fabbretti E, Borelli V and Zabucchi G: Mast cell
activation by myelin through scavenger receptor. J Neuroimmunol.
200:27–40. 2008.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Zhang S, Dong H, Zhang X, Li N, Sun J and
Qian Y: Cerebral mast cells contribute to postoperative cognitive
dysfunction by promoting blood brain barrier disruption. Behav
Brain Res. 298(Pt B):158–166. 2016.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Dong H, Zhang X, Wang Y, Zhou X, Qian Y
and Zhang S: Suppression of brain mast cells degranulation inhibits
microglial activation and central nervous system inflammation. Mol
Neurobiol. 54:997–1007. 2017.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Kempuraj D, Selvakumar GP, Thangavel R,
Ahmed ME, Zaheer S, Kumar KK, Yelam A, Kaur H, Dubova I, Raikwar
SP, et al: Glia maturation factor and mast cell-dependent
expression of inflammatory mediators and proteinase activated
receptor-2 in neuroinflammation. J Alzheimers Dis. 66:1117–1129.
2018.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Hagiyama M, Furuno T, Hosokawa Y, Iino T,
Ito T, Inoue T, Nakanishi M, Murakami Y and Ito A: Enhanced
nerve-mast cell interaction by a neuronal short isoform of cell
adhesion molecule-1. J Immunol. 186:5983–5992. 2011.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Wilhelm M, Silver R and Silverman AJ:
Central nervous system neurons acquire mast cell products via
transgranulation. Eur J Neurosci. 22:2238–2248. 2005.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Kulka M, Sheen CH, Tancowny BP, Grammer LC
and Schleimer RP: Neuropeptides activate human mast cell
degranulation and chemokine production. Immunology. 123:398–410.
2008.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Masini E, Fantozzi R, Conti A, Blandina P,
Brunelleschi S and Mannaioni PF: Mast cell heterogeneity in
response to cholinergic stimulation. Int Arch Allergy Appl Immunol.
77:184–185. 1985.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Skaper SD, Facci L, Kee WJ and Strijbos
PJ: Potentiation by histamine of synaptically mediated
excitotoxicity in cultured hippocampal neurones: A possible role
for mast cells. J Neurochem. 76:47–55. 2001.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Ossovskaya VS and Bunnett NW:
Protease-activated receptors: Contribution to physiology and
disease. Physiol Rev. 84:579–621. 2004.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Claes SJ: Corticotropin-releasing hormone
(CRH) in psychiatry: From stress to psychopathology. Ann Med.
36:50–61. 2004.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Karagkouni A, Alevizos M and Theoharides
TC: Effect of stress on brain inflammation and multiple sclerosis.
Autoimmun Rev. 12:947–953. 2013.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Cao J, Papadopoulou N, Kempuraj D, Boucher
WS, Sugimoto K, Cetrulo CL and Theoharides TC: Human mast cells
express corticotropin-releasing hormone (CRH) receptors and CRH
leads to selective secretion of vascular endothelial growth factor.
J Immunol. 174:7665–7675. 2005.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Cao J, Boucher W, Kempuraj D, Donelan JM
and Theoharides TC: Acute stress and intravesical
corticotropin-releasing hormone induces mast cell dependent
vascular endothelial growth factor release from mouse bladder
explants. J Urol. 176:1208–1213. 2006.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Rozniecki JJ, Sahagian GG, Kempuraj D, Tao
K, Jocobson S, Zhang B and Theoharides TC: Brain metastases of
mouse mammary adenocarcinoma is increased by acute stress. Brain
Res. 1366:204–210. 2010.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Kritas SK, Caraffa A, Antinolfi P, Saggini
A, Pantalone A, Rosati M, Tei M, Speziali A, Saggini R, Pandolfi F,
et al: Nerve growth factor interactions with mast cells. Int J
Immunopathol Pharmacol. 27:15–19. 2014.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Kempuraj D, Mentor S, Thangavel R, Ahmed
ME, Selvakumar GP, Raikwar SP, Dubova I, Zaheer S, Iyer SS and
Zaheer A: Mast cells in stress, pain, blood-brain barrier,
neuroinflammation and Alzheimer's disease. Front Cell Neurosci.
13(54)2019.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Papadopoulou NG, Oleson L, Kempuraj D,
Donelan J, Cetrulo CL and Theoharides TC: Regulation of
corticotropin-releasing hormone receptor-2 expression in human cord
blood-derived cultured mast cells. J Mol Endocrinol. 35:R1–R8.
2005.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Ayyadurai S, Gibson AJ, D'Costa S, Overman
EL, Sommerville LJ, Poopal AC, Mackey E, Li Y and Moeser AJ:
Frontline science: Corticotropin-releasing factor receptor subtype
1 is a critical modulator of mast cell degranulation and
stress-induced pathophysiology. J Leukoc Biol. 102:1299–1312.
2017.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Kempuraj D, Papadopoulou NG, Lytinas M,
Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W,
Christodoulou S, Athanassiou A and Theoharides TC:
Corticotropin-releasing hormone and its structurally related
urocortin are synthesized and secreted by human mast cells.
Endocrinology. 145:43–48. 2004.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Kempuraj D, Thangavel R, Selvakumar GP,
Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer
S and Zaheer A: Brain and peripheral atypical inflammatory
mediators potentiate neuroinflammation and neurodegeneration. Front
Cell Neurosci. 11(216)2017.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Pedersen WA, McCullers D, Culmsee C,
Haughey NJ, Herman JP and Mattson MP: Corticotropin-releasing
hormone protects neurons against insults relevant to the
pathogenesis of Alzheimer's disease. Neurobiol Dis. 8:492–503.
2001.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Morgese MG, Schiavone S and Trabace L:
Emerging role of amyloid beta in stress response: Implication for
depression and diabetes. Eur J Pharmacol. 817:22–29.
2017.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Zhang C and Rissman RA:
Corticotropin-releasing factor receptor-1 modulates biomarkers of
DNA oxidation in Alzheimer's disease mice. PLoS One.
12(e181367)2017.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Asadi S and Theoharides TC:
Corticotropin-releasing hormone and extracellular mitochondria
augment IgE-stimulated human mast-cell vascular endothelial growth
factor release, which is inhibited by luteolin. J
Neuroinflammation. 9(85)2012.PubMed/NCBI View Article : Google Scholar
|
|
112
|
de Pablos RM, Herrera AJ, Espinosa-Oliva
AM, Sarmiento M, Munoz MF, Machado A and Venero JL: Chronic stress
enhances microglia activation and exacerbates death of nigral
dopaminergic neurons under conditions of inflammation. J
Neuroinflammation. 11(34)2014.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Strbian D, Kovanen PT,
Karjalainen-Lindsberg ML, Tatlisumak T and Lindsberg PJ: An
emerging role of mast cells in cerebral ischemia and hemorrhage.
Ann Med. 41:438–450. 2009.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Profaci CP, Munji RN, Pulido RS and
Daneman R: The blood-brain barrier in health and disease: Important
unanswered questions. J Exp Med. 217(e20190062)2020.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Silver R and Curley JP: Mast cells on the
mind: New insights and opportunities. Trends Neurosci. 36:513–521.
2013.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Skaper SD: Mast cell-glia dialogue in
chronic pain and neuropathic pain: Blood-brain barrier
implications. CNS Neurol Disord Drug Targets. 15:1072–1078.
2016.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Lindsberg PJ, Strbian D and
Karjalainen-Lindsberg ML: Mast cells as early responders in the
regulation of acute blood-brain barrier changes after cerebral
ischemia and hemorrhage. J Cereb Blood Flow Metab. 30:689–702.
2010.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Tchougounova E, Lundequist A, Fajardo I,
Winberg JO, Abrink M and Pejler G: A key role for mast cell chymase
in the activation of pro-matrix metalloprotease-9 and pro-matrix
metalloprotease-2. J Biol Chem. 280:9291–9296. 2005.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Lapilover EG, Lippmann K, Salar S,
Maslarova A, Dreier JP, Heinemann U and Friedman A: Peri-infarct
blood-brain barrier dysfunction facilitates induction of spreading
depolarization associated with epileptiform discharges. Neurobiol
Dis. 48:495–506. 2012.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Mattila OS, Strbian D, Saksi J,
Pikkarainen TO, Rantanen V, Tatlisumak T and Lindsberg PJ: Cerebral
mast cells mediate blood-brain barrier disruption in acute
experimental ischemic stroke through perivascular gelatinase
activation. Stroke. 42:3600–3605. 2011.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Christy AL, Walker ME, Hessner MJ and
Brown MA: Mast cell activation and neutrophil recruitment promotes
early and robust inflammation in the meninges in EAE. J Autoimmun.
42:50–61. 2013.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Rochfort KD and Cummins PM:
Cytokine-mediated dysregulation of zonula occludens-1 properties in
human brain microvascular endothelium. Microvasc Res. 100:48–53.
2015.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Liu H, Luiten PG, Eisel UL, Dejongste MJ
and Schoemaker RG: Depression after myocardial infarction:
TNF-α-induced alterations of the blood-brain barrier and its
putative therapeutic implications. Neurosci Biobehav Rev.
37:561–572. 2013.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Esposito P, Gheorghe D, Kandere K, Pang X,
Connolly R, Jacobson S and Theoharides TC: Acute stress increases
permeability of the blood-brain-barrier through activation of brain
mast cells. Brain Res. 888:117–127. 2001.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Alvarez JI, Cayrol R and Prat A:
Disruption of central nervous system barriers in multiple
sclerosis. Biochim Biophys Acta. 1812:252–264. 2011.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Bell RD, Winkler EA, Sagare AP, Singh I,
LaRue B, Deane R and Zlokovic BV: Pericytes control key
neurovascular functions and neuronal phenotype in the adult brain
and during brain aging. Neuron. 68:409–427. 2010.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Henkel JS, Beers DR, Wen S, Bowser R and
Appel SH: Decreased mRNA expression of tight junction proteins in
lumbar spinal cords of patients with ALS. Neurology. 72:1614–1616.
2009.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Khalil MH, Silverman AJ and Silver R: Mast
cells in the rat brain synthesize gonadotropin-releasing hormone. J
Neurobiol. 56:113–124. 2003.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Corrigan F, Mander KA, Leonard AV and Vink
R: Neurogenic inflammation after traumatic brain injury and its
potentiation of classical inflammation. J Neuroinflammation.
13(264)2016.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Theoharides TC, Asadi S and Patel AB:
Focal brain inflammation and autism. J Neuroinflammation.
10(46)2013.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Strbian D, Karjalainen-Lindsberg ML,
Tatlisumak T and Lindsberg PJ: Cerebral mast cells regulate early
ischemic brain swelling and neutrophil accumulation. J Cereb Blood
Flow Metab. 26:605–612. 2006.PubMed/NCBI View Article : Google Scholar
|
|
132
|
van der Schans J, Pleiter JC, de Vries TW,
Schuiling-Veninga CC, Bos JH, Hoekstra PJ and Hak E: Association
between medication prescription for atopic diseases and
attention-deficit/hyperactivity disorder. Ann Allergy Asthma
Immunol. 117:186–191. 2016.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Genuneit J, Braig S, Brandt S, Wabitsch M,
Florath I, Brenner H and Rothenbacher D: Infant atopic eczema and
subsequent attention-deficit/hyperactivity disorder-a prospective
birth cohort study. Pediatr Allergy Immunol. 25:51–56.
2014.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Allred EN, Dammann O, Fichorova RN, Hooper
SR, Hunter SJ, Joseph RM, Kuban K, Leviton A, O'Shea TM and Scott
MN: ELGAN Study ADHD symptoms writing group for the ELGAN Study
Investigators: Systemic inflammation during the first postnatal
month and the risk of attention deficit hyperactivity disorder
characteristics among 10 year-old children born extremely preterm.
J Neuroimmune Pharmacol. 12:531–543. 2017.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Nielsen PR, Benros ME and Dalsgaard S:
Associations between autoimmune diseases and
attention-deficit/hyperactivity disorder: A nationwide study. J Am
Acad Child Adolesc Psychiatry. 56:234–240. 2017.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Hegvik TA, Instanes JT, Haavik J,
Klungsoyr K and Engeland A: Associations between
attention-deficit/hyperactivity disorder and autoimmune diseases
are modified by sex: A population-based cross-sectional study. Eur
Child Adolesc Psychiatry. 27:663–675. 2018.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Wang LJ, Yu YH, Fu ML, Yeh WT, Hsu JL,
Yang YH, Chen WJ, Chiang BL and Pan WH: Attention
deficit-hyperactivity disorder is associated with allergic symptoms
and low levels of hemoglobin and serotonin. Sci Rep.
8(10229)2018.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Segman RH, Meltzer A, Gross-Tsur V, Kosov
A, Frisch A, Inbar E, Darvasi A, Levy S, Goltser T, Weizman A and
Galili-Weisstub E: Preferential transmission of interleukin-1
receptor antagonist alleles in attention deficit hyperactivity
disorder. Mol Psychiatry. 7:72–74. 2002.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Ribases M, Hervas A, Ramos-Quiroga JA,
Bosch R, Bielsa A, Gastaminza X, Fernandez-Anguiano M, Nogueira M,
Gomez-Barros N, Valero S, et al: Association study of 10 genes
encoding neurotrophic factors and their receptors in adult and
child attention-deficit/hyperactivity disorder. Biol Psychiatry.
63:935–945. 2008.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Cortese S and Vincenzi B: Obesity and
ADHD: Clinical and neurobiological implications. Curr Top Behav
Neurosci. 9:199–218. 2012.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Cortese S, Angriman M, Comencini E,
Vincenzi B and Maffeis C: Association between inflammatory
cytokines and ADHD symptoms in children and adolescents with
obesity: A pilot study. Psychiatry Res. 278:7–11. 2019.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Boyle CA, Boulet S, Schieve LA, Cohen RA,
Blumberg SJ, Yeargin-Allsopp M, Visser S and Kogan MD: Trends in
the prevalence of developmental disabilities in US children,
1997-2008. Pediatrics. 127:1034–1042. 2011.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Olfson M, Blanco C, Wang S, Laje G and
Correll CU: National trends in the mental health care of children,
adolescents, and adults by office-based physicians. JAMA
Psychiatry. 71:81–90. 2014.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Rivera HM, Christiansen KJ and Sullivan
EL: The role of maternal obesity in the risk of neuropsychiatric
disorders. Front Neurosci. 9(194)2015.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Sullivan EL, Riper KM, Lockard R and
Valleau JC: Maternal high-fat diet programming of the
neuroendocrine system and behavior. Horm Behav. 76:153–161.
2015.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Petra AI, Panagiotidou S, Hatziagelaki E,
Stewart JM, Conti P and Theoharides TC: Gut-microbiota-brain axis
and its effect on neuropsychiatric disorders with suspected immune
dysregulation Clin. Ther. 37:984–995. 2015.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Anand D, Colpo GD, Zeni G, Zeni CP and
Teixeira AL: Attention-deficit/hyperactivity disorder and
inflammation: What does current knowledge tell Us? A systematic
review. Front Psychiatry. 8(228)2017.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Darwish AH, Elgohary TM and Nosair NA:
Serum interleukin-6 level in children with attention-deficit
hyperactivity disorder (ADHD). J Child Neurol. 34:61–67.
2019.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Donfrancesco R, Nativio P, Borrelli E,
Giua E, Andriola E, Villa MP and DI Trani M: Serum cytokines in
paediatric neuropsychiatric syndromes: Focus on attention deficit
hyperactivity disorder. Minerva Pediatr: 2016 (Epub ahead of
print).
|
|
150
|
O'Shea TM, Joseph RM, Kuban KC, Allred EN,
Ware J, Coster T, Fichorova RN, Dammann O and Leviton A: ELGAN
Study Investigators: Elevated blood levels of inflammation-related
proteins are associated with an attention problem at age 24 mo in
extremely preterm infants. Pediatr Res. 75:781–787. 2014.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Donfrancesco R, Nativio P, Di Benedetto A,
Villa MP, Andriola E, Melegari MG, Cipriano E and Di Trani M:
Anti-yo antibodies in children with ADHD: First results about serum
cytokines. J Atten Disord 2016 (Epub ahead of print).
|
|
152
|
Oades RD, Dauvermann MR, Schimmelmann BG,
Schwarz MJ and Myint AM: Attention-deficit hyperactivity disorder
(ADHD) and glial integrity: S100B, cytokines and kynurenine
metabolism-effects of medication. Behav Brain Funct.
6(29)2010.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Rand KM, Austin NC, Inder TE, Bora S and
Woodward LJ: Neonatal infection and later neurodevelopmental risk
in the very preterm infant. J Pediatr. 170:97–104. 2016.PubMed/NCBI View Article : Google Scholar
|
|
154
|
van Tilborg E, Heijnen CJ, Benders MJ, van
Bel F, Fleiss B, Gressens P and Nijboer CH: Impaired
oligodendrocyte maturation in preterm infants: Potential
therapeutic targets. Prog Neurobiol. 136:28–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Vogel SWN, Bijlenga D, Verduijn J, Bron
TI, Beekman ATF, Kooij JJS and Penninx BWJH:
Attention-deficit/hyperactivity disorder symptoms and
stress-related biomarkers. Psychoneuroendocrinology. 79:31–39.
2017.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Chudal R, Brown AS, Gyllenberg D,
Hinkka-Yli-Salomaki S, Sucksdorff M, Surcel HM, Upadhyaya S and
Sourander A: Maternal serum C-reactive protein (CRP) and offspring
attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc
Psychiatry. 29:239–247. 2020.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Kozlowska A, Wojtacha P, Rowniak M,
Kolenkiewicz M and Huang ACW: ADHD pathogenesis in the immune,
endocrine and nervous systems of juvenile and maturating SHR and
WKY rats. Psychopharmacology (Berl). 236:2937–2958. 2019.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Saedisomeolia A, Samadi M, Gholami F,
Seyedi M, Effatpanah M, Hashemi R, Abdolahi M and Honarvar NM:
Vitamin d's molecular action mechanism in attention-deficit/
hyperactivity disorder: A review of evidence. CNS Neurol Disord
Drug Targets. 17:280–290. 2018.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Verlaet AAJ, Maasakkers CM, Hermans N and
Savelkoul HFJ: Rationale for dietary antioxidant treatment of ADHD.
Nutrients. 10(E405)2018.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Cortese S and Angriman M:
Attention-deficit/hyperactivity disorder, iron deficiency, and
obesity: Is there a link? Postgrad Med. 126:155–170.
2014.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Kean JD, Camfield D, Sarris J, Kras M,
Silberstein R, Scholey A and Stough C: A randomized controlled
trial investigating the effects of PCSO-524, a patented oil extract
of the New Zealand green lipped mussel (Perna canaliculus), on the
behaviour, mood, cognition and neurophysiology of children and
adolescents (aged 6-14 years) experiencing clinical and
sub-clinical levels of hyperactivity and inattention: Study
protocol ACTRN12610000978066. Nutr J. 12(100)2013.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Ghunaim N, Gronlund H, Kronqvist M,
Gronneberg R, Soderstrom L, Ahlstedt S and van Hage-Hamsten M:
Antibody profiles and self-reported symptoms to pollen-related food
allergens in grass pollen-allergic patients from northern Europe.
Allergy. 60:185–191. 2005.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Zhou L, Chen L, Li X, Li T, Dong Z and
Wang YT: Food allergy induces alteration in brain inflammatory
status and cognitive impairments. Behav Brain Res. 364:374–382.
2019.PubMed/NCBI View Article : Google Scholar
|
|
164
|
de Theije CG, Bavelaar BM, Lopes da Silva
S, Korte SM, Olivier B, Garssen J and Kraneveld AD: Food allergy
and food-based therapies in neurodevelopmental disorders. Pediatr
Allergy Immunol. 25:218–226. 2014.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Sarlus H, Höglund CO, Karshikoff B, Wang
X, Lekander M, Schultzberg M and Oprica M: Allergy influences the
inflammatory status of the brain and enhances tau-phosphorylation.
J Cell Mol Med. 16:2401–2412. 2012.PubMed/NCBI View Article : Google Scholar
|
|
166
|
Niggemann B, Reibel S, Roehr CC, Felger D,
Ziegert M, Sommerfeld C and Wahn U: Predictors of positive food
challenge outcome in non-IgE-mediated reactions to food in children
with atopic dermatitis. J Allergy Clin Immunol. 108:1053–1058.
2001.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Milosz M, Demkow U and Wolanczyk T:
Relation between attention-deficit hyperactivity disorder and
IgE-dependent allergy in pediatric patients. Adv Exp Med Biol.
1096:105–109. 2018.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Jiang X, Shen C, Dai Y, Jiang F, Li S,
Shen X, Hu Y and Li F: Early food allergy and respiratory allergy
symptoms and attention-deficit/hyperactivity disorder in Chinese
children: A cross-sectional study. Pediatr Allergy Immunol.
29:402–409. 2018.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Boris M and Mandel FS: Foods and additives
are common causes of the attention deficit hyperactive disorder in
children. Ann Allergy. 72:462–468. 1994.PubMed/NCBI
|
|
170
|
Verlaet AA, Noriega DB, Hermans N and
Savelkoul HF: Nutrition, immunological mechanisms and dietary
immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 23:519–529.
2014.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Ritz BW and Lord RS: Case study: The
effectiveness of a dietary supplement regimen in reducing
IgG-mediated food sensitivity in ADHD. Altern Ther Health Med.
11:72–75. 2005.PubMed/NCBI
|
|
172
|
Miyazaki C, Koyama M, Ota E, Swa T, Mlunde
LB, Amiya RM, Tachibana Y, Yamamoto-Hanada K and Mori R: Allergic
diseases in children with attention deficit hyperactivity disorder:
A systematic review and meta-analysis. BMC Psychiatry.
17(120)2017.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Johnston LK, Chien KB and Bryce PJ: The
immunology of food allergy. J Immunol. 192:2529–2534.
2014.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Pelsser LM, Buitelaar JK and Savelkoul HF:
ADHD as a (non) allergic hypersensitivity disorder: A hypothesis.
Pediatr Allergy Immunol. 20:107–112. 2009.PubMed/NCBI View Article : Google Scholar
|
|
175
|
Suwan P, Akaramethathip D and Noipayak P:
Association between allergic sensitization and attention deficit
hyperactivity disorder (ADHD). Asian Pac J Allergy Immunol.
29:57–65. 2011.PubMed/NCBI
|
|
176
|
Rijnierse A, Nijkamp FP and Kraneveld AD:
Mast cells and nerves tickle in the tummy: Implications for
inflammatory bowel disease and irritable bowel syndrome. Pharmacol
Ther. 116:207–235. 2007.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Gui XY: Mast cells: A possible link
between psychological stress, enteric infection, food allergy and
gut hypersensitivity in the irritable bowel syndrome. J
Gastroenterol Hepatol. 13:980–989. 1998.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Hirano T, Taga T, Nakano N, Yasukawa K,
Kashiwamura S, Shimizu K, Nakajima K, Pyun KH and Kishimoto T:
Purification to homogeneity and characterization of human B-cell
differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA.
82:5490–5494. 1985.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Li X, Chauhan A, Sheikh AM, Patil S,
Chauhan V, Li XM, Ji L, Brown T and Malik M: Elevated immune
response in the brain of autistic patients. J Neuroimmunol.
207:111–116. 2009.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Needham BD, Tang W and Wu WL: Searching
for the gut microbial contributing factors to social behavior in
rodent models of autism spectrum disorder. Dev Neurobiol.
78:474–499. 2018.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Meeking MM, MacFabe DF, Mepham JR, Foley
KA, Tichenoff LJ, Boon FH, Kavaliers M and Ossenkopp KP: Propionic
acid induced behavioural effects of relevance to autism spectrum
disorder evaluated in the hole board test with rats. Prog
Neuropsychopharmacol Biol Psychiatry. 97(109794)2020.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Zass LJ, Hart SA, Seedat S, Hemmings SM
and Malan-Muller S: Neuroinflammatory genes associated with
post-traumatic stress disorder: Implications for comorbidity.
Psychiatr Genet. 27:1–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Nakamura Y, Ishimaru K, Shibata S and
Nakao A: Regulation of plasma histamine levels by the mast cell
clock and its modulation by stress. Sci Rep.
7(39934)2017.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Passos IC, Vasconcelos-Moreno MP, Costa
LG, Kunz M, Brietzke E, Quevedo J, Salum G, Magalhaes PV,
Kapczinski F and Kauer-Sant'Anna M: Inflammatory markers in
post-traumatic stress disorder: A systematic review, meta-analysis,
and meta-regression. Lancet Psychiatry. 2:1002–1012.
2015.PubMed/NCBI View Article : Google Scholar
|
|
185
|
Geracioti TD Jr, Carpenter LL, Owens MJ,
Baker DG, Ekhator NN, Horn PS, Strawn JR, Sanacora G, Kinkead B,
Price LH and Nemeroff CB: Elevated cerebrospinal fluid substance p
concentrations in posttraumatic stress disorder and major
depression. Am J Psychiatry. 163:637–643. 2006.PubMed/NCBI View Article : Google Scholar
|
|
186
|
O'Donovan A, Cohen BE, Seal KH, Bertenthal
D, Margaretten M, Nishimi K and Neylan TC: Elevated risk for
autoimmune disorders in Iraq and afghanistan veterans with
posttraumatic stress disorder. Biol Psychiatry. 77:365–374.
2015.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Hendriksen E, van Bergeijk D, Oosting RS
and Redegeld FA: Mast cells in neuroinflammation and brain
disorders. Neurosci Biobehav Rev. 79:119–133. 2017.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Ahmed ME, Iyer S, Thangavel R, Kempuraj D,
Selvakumar GP, Raikwar SP, Zaheer S and Zaheer A: Co-localization
of glia maturation factor with NLRP3 inflammasome and autophagosome
markers in human Alzheimer's disease brain. J Alzheimers Dis.
60:1143–1160. 2017.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Xiong Z, Thangavel R, Kempuraj D, Yang E,
Zaheer S and Zaheer A: Alzheimer's disease: Evidence for the
expression of interleukin-33 and its receptor ST2 in the brain. J
Alzheimers Dis. 40:297–308. 2014.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Shaik-Dasthagirisaheb YB and Conti P: The
role of mast cells in Alzheimer's disease. Adv Clin Exp Med.
25:781–787. 2016.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Tagen M, Elorza A, Kempuraj D, Boucher W,
Kepley CL, Shirihai OS and Theoharides TC: Mitochondrial uncoupling
protein 2 inhibits mast cell activation and reduces histamine
content. J Immunol. 183:6313–6319. 2009.PubMed/NCBI View Article : Google Scholar
|
|
192
|
Nelson RB, Siman R, Iqbal MA and Potter H:
Identification of a chymotrypsin-like mast cell protease in rat
brain capable of generating the N-terminus of the Alzheimer amyloid
beta-protein. J Neurochem. 61:567–577. 1993.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Ibrahim MZ, Reder AT, Lawand R, Takash W
and Sallouh-Khatib S: The mast cells of the multiple sclerosis
brain. J Neuroimmunol. 70:131–138. 1996.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Russi AE and Brown MA: The meninges: New
therapeutic targets for multiple sclerosis. Transl Res.
165:255–269. 2015.PubMed/NCBI View Article : Google Scholar
|
|
195
|
Theoharides TC, Asadi S, Panagiotidou S
and Weng Z: The ‘missing link’ in autoimmunity and autism:
Extracellular mitochondrial components secreted from activated live
mast cells. Autoimmun Rev. 12:1136–1142. 2013.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Kawasaki H, Chang HW, Tseng HC, Hsu SC,
Yang SJ, Hung CH, Zhou Y and Huang SK: A tryptophan metabolite,
kynurenine, promotes mast cell activation through aryl hydrocarbon
receptor. Allergy. 69:445–452. 2014.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Hermine O, Lortholary O, Leventhal PS,
Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmerini F,
Hanssens K, Yang Y, et al: Case-control cohort study of patients'
perceptions of disability in mastocytosis. PLoS One.
3(e2266)2008.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Georgin-Lavialle S, Moura DS, Salvador A,
Chauvet-Gelinier JC, Launay JM, Damaj G, Cote F, Soucie E,
Chandesris MO, Barete S, et al: Mast cells' involvement in
inflammation pathways linked to depression: Evidence in
mastocytosis. Mol Psychiatry. 21:1511–1516. 2016.PubMed/NCBI View Article : Google Scholar
|
|
199
|
Couturier N, Zappulla JP, Lauwers-Cances
V, Uro-Coste E, Delisle MB, Clanet M, Montagne L, Van der Valk P,
Bö L and Liblau RS: Mast cell transcripts are increased within and
outside multiple sclerosis lesions. J Neuroimmunol. 195:176–185.
2008.PubMed/NCBI View Article : Google Scholar
|
